HeartSciences Inc. HSCS
Set alert
As of Nov 3, 1:53 PM ET
- YTD
- -2.59%
- 1 year
- +2.73%
- Open
- 3.16
- Prev close
- 2.99
- Mkt cap
- 14.96M
- Vol
- 31.04K
- Avg vol
- 164.85K
- EPS
- -3.21
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.98
- High
- 3.16
- Forward P/E
- -0.61
- Beta
- 3.29
- Short ratio
- 2.41
- Inst. own
- 1.43%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Sep 12, 2024
- 50-d avg
- 3.25
- 200-d avg
- 5.57
- 1y target
- 13.50
News
-
5 days ago benzinga.com
Fortitude Mining Holdings' 15 MW Site In Nebraska Participating In Southwest Power Pool Wholesale Electricity Markets
Fortitude Mining Holdings, Inc. ("Fortitude" or the "Company"), a vertically integrated digital asset mining platform anchored in Zcash, today announced that its 15-megawatt (MW) facility in Aurora,
1 week ago zacks.com
Is HeartSciences Inc. (HSCS) Stock Outpacing Its Medical Peers This Year?
Here is how HeartSciences Inc. (HSCS) and ImmunityBio (IBRX) have performed compared to their sector so far this year.
1 week ago globenewswire.com
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
Definitive proxy statement filed with the SEC, marking an important milestone toward completion of the proposed transaction HeartSciences Board of Directors unanimously recommends shareholders vote…
-
4 weeks ago benzinga.com
FDA Grants 510(k) Clearance For HeartSciences’ MyoVista wavECGTM Device As 12-Lead Resting Electrocardiograph
HeartSciences Inc. (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or
4 weeks ago globenewswire.com
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
Southlake, TX, Oct. 06, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing…
4 weeks ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Jaguar Health (NASDAQ:JAGX) stock moved upwards by 34.0% to $6.34 during Tuesday's pre-market session. The company's market cap stands at $2.4 million. Option Care Health (NASDAQ:OPCH) stock…
4 weeks ago benzinga.com
Why Option Care Health Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Option Care Health jumped 23.8% on reports McKesson and CD&R may acquire it; Freight Technologies led gainers, while NFT Ltd. led decliners.
1 month ago businesswire.com
Fortitude Appoints Kimberly Pittman as Chief Legal Officer
FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. (“Fortitude” or the “Company”), a vertically-integrated digital asset mining platform anchored in Zcash, today announced the…
-
1 month ago benzinga.com
HeartSciences Files Prospectus Shelf Registration For $200M Mixed Securities
HEARTSCIENCES INC. PROSPECTUS $200,000,000 Common Stock Preferred Stock Debt Securities Warrants Rights Units This prospectus will allow HeartSciences Inc. (the "Company", "we", "us" or
1 month ago globenewswire.com
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with closing expected in Q4 calendar 2026
1 month ago zacks.com
HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates
HeartSciences Inc. (HSCS) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to a loss of $1.58 per share a year ago.
-
1 month ago benzinga.com
Heart Test Laboratories Q1 EPS $(0.86) Up From $(1.58) YoY, Sales $2.100K Up From $1.900K YoY
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.86) per share. This is a 45.57 percent increase over losses of $(1.58) per share from the same period last year. The company…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-market session. The market value of their outstanding shares is at $40.0 billion. The company's, Q2…
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session. The company's market cap stands at $6.2 million. As per the news, the Q2 earnings report came out 2…
2 months ago globenewswire.com
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
Fortitude purchased approximately $1,000,000 of HeartSciences' shares of common stock at $2.43 per share, a 22% premium to the closing price on the purchase date The exchange ratio under the merger…
3 months ago gurufocus.com
Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem
Fortitude Mining Holdings, Inc. ("Fortitude" or the âCompanyâ), a vertically-integrated digital asset mining platform anchored in Zcash today announced it h
3 months ago globenewswire.com
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company's shareholders Fiscal 2026 saw the full commercial launch…
-
3 months ago benzinga.com
Fortitude Mining Announces Energization Of Its New Facility In Grand Island, Nebraska
With 12 MW of power capacity now delivered, Fortitude has completed construction, brought the facility online, and validated its electrical infrastructure ahead of full-scale operations. The…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Gossamer Bio (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market session. The company's market cap stands at $66.4 million. ProMIS Neurosciences (NASDAQ:PMN) shares…
-
3 months ago benzinga.com
Heart Test Laboratories Q4 EPS $(0.87) Misses $(0.73) Estimate
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.73) by 19.18 percent. This is a 53.23 percent increase over…
3 months ago globenewswire.com
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
Company believes proposed Fortitude merger represents a significant opportunity for the Company's shareholders; preliminary proxy statement in connection with the Proposed Transaction expected to be…
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Aditxt (NASDAQ:ADTX) shares increased by 151.6% to $0.05 during Tuesday's regular session. Atlantic International (NASDAQ:ATLN) stock rose 143.31% to $1.07. The market value of their…
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market session. The company's market cap stands at $5.6 million. Boundless Bio (NASDAQ:BOLD) shares rose 62.85% to…
-
4 months ago benzinga.com
Fortitude Mining, HeartSciences Strike Merger Deal; Combined Entity Anticipated To Trade On Nasdaq Under TUDE Ticker
Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences"), an AI-powered medical
4 months ago businesswire.com
Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets
FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (Nasdaq: HSCS)…
4 months ago globenewswire.com
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents
Patent covers machine-learning models that use ECG data to estimate echocardiogram parameters indicative of diastolic function Patent covers machine-learning models that use ECG data to estimate…
4 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
5 months ago benzinga.com
HeartSciences Announces Commercial Release Of MyoVista Insights Version 1.3, Platform Update Introducing MyoVista Insights AI-ECG Algorithm Marketplace
HeartSciences Inc. (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or "EKG") through the…
5 months ago globenewswire.com
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
Bunkerhill Health's FDA-cleared ECG-EF algorithm for the detection of reduced ejection fraction becomes the first cleared AI-ECG algorithm available through MyoVista Insights, advancing…
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
5 months ago globenewswire.com
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
Agreement follows Cibolo Health's endorsement of MyoVista Insights for its network of 127 independent hospitals and reflects continued commercial momentum for HeartSciences' ECG management platform…
-
6 months ago benzinga.com
HeartSciences Signs Commercial Agreement With St. Vincent Health, Critical Access Hospital Serving Lake County, Colorado, To Deploy MyoVista Insights Platform
HeartSciences Inc. (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or "EKG") through the…
6 months ago globenewswire.com
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
Agreement with St. Vincent Health marks HeartSciences' transition from early adopter installations to commercial SaaS deployments following the full launch of MyoVista Insights at the American…
6 months ago defenseworld.net
Analyzing Rennova Health (OTCMKTS:RNVA) & HeartSciences (NASDAQ:HSCS)
Rennova Health (OTCMKTS:RNVA - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
6 months ago globenewswire.com
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
Southlake, TX, April 14, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) a healthcare information technology (“HIT”) company focused on advancing…
6 months ago defenseworld.net
Comparing 10x Genomics (NASDAQ:TXG) and HeartSciences (NASDAQ:HSCS)
10x Genomics (NASDAQ: TXG - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based…
7 months ago defenseworld.net
Hinge Health (NYSE:HNGE) versus HeartSciences (NASDAQ:HSCS) Financial Analysis
HeartSciences (NASDAQ: HSCS - Get Free Report) and Hinge Health (NYSE: HNGE - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based…
7 months ago globenewswire.com
HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
Southlake, TX , March 25, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on…
7 months ago benzinga.com
Pfizer To Rally More Than 34%? Here Are 10 Top Analyst Forecasts For Tuesday
Analysts change ratings & price targets for HSCS, ONDS, STRO, PFE, HST, CABA, INSM, PVH. See full list & how others rate each stock.
-
7 months ago benzinga.com
Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $8
Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $9.2 to $8.
-
7 months ago benzinga.com
Heart Test Laboratories Q3 EPS $(0.63) Beats $(0.86) Estimate
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.86) by 26.74 percent. This is a 75.49 percent increase over…
-
10 months ago benzinga.com
Ascendiant Capital Maintains Buy on HeartSciences, Raises Price Target to $9.2
Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and raises the price target from $9 to $9.2.
-
10 months ago benzinga.com
CORRECTION: Heart Test Laboratories Q2 EPS $(0.85) Beats $(1.69) Estimate, Sales $2.419K Miss $50.000K Estimate
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.69) by 49.7 percent. This is a 62.56 percent increase over losses…
-
11 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
1 year ago benzinga.com
Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $9
Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 to $9.
-
1 year ago benzinga.com
HeartSciences Q1 EPS $(1.58) Beats $(2.09) Estimate, Sales $1.900M
HeartSciences Inc. (NASDAQ:HSCS) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(2.09) by 24.4 percent. This is a 40.15 percent increase over losses of…
-
1 year ago benzinga.com
Heart Test Laboratories Q4 EPS $(1.86) Beats $(2.25) Estimate, Sales $4.350M
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(1.86) per share which beat the analyst consensus estimate of $(2.25) by 17.33 percent. The company reported $4.350 million in…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session